How antibody therapy affects the breadth of COVID mRNA vaccines

Nearly three years into the pandemic, many of us now carry antibodies against the virus—due to an infection or two, a few doses of mRNA vaccine, or a round of monoclonal-antibody treatment. But not all immune responses ...

page 1 from 40